These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

411 related articles for article (PubMed ID: 16595489)

  • 1. Effect of intramyocardial injection of autologous bone marrow-derived mononuclear cells on perfusion, function, and viability in patients with drug-refractory chronic ischemia.
    Beeres SL; Bax JJ; Dibbets P; Stokkel MP; Zeppenfeld K; Fibbe WE; van der Wall EE; Schalij MJ; Atsma DE
    J Nucl Med; 2006 Apr; 47(4):574-80. PubMed ID: 16595489
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Usefulness of intramyocardial injection of autologous bone marrow-derived mononuclear cells in patients with severe angina pectoris and stress-induced myocardial ischemia.
    Beeres SL; Bax JJ; Kaandorp TA; Zeppenfeld K; Lamb HJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; de Roos A; van der Wall EE; Schalij MJ; Atsma DE
    Am J Cardiol; 2006 May; 97(9):1326-31. PubMed ID: 16635605
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Sustained effect of autologous bone marrow mononuclear cell injection in patients with refractory angina pectoris and chronic myocardial ischemia: twelve-month follow-up results.
    Beeres SL; Bax JJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; van der Wall EE; Schalij MJ; Atsma DE
    Am Heart J; 2006 Oct; 152(4):684.e11-6. PubMed ID: 16996834
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Intramyocardial bone marrow cell injection for chronic myocardial ischemia: a randomized controlled trial.
    van Ramshorst J; Bax JJ; Beeres SL; Dibbets-Schneider P; Roes SD; Stokkel MP; de Roos A; Fibbe WE; Zwaginga JJ; Boersma E; Schalij MJ; Atsma DE
    JAMA; 2009 May; 301(19):1997-2004. PubMed ID: 19454638
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Intramyocardial injection of bone marrow mononuclear cells in chronic myocardial ischemia patients after previous placebo injection improves myocardial perfusion and anginal symptoms: an intra-patient comparison.
    Rodrigo SF; van Ramshorst J; Beeres SL; Al Younis I; Dibbets-Schneider P; de Roos A; Fibbe WE; Zwaginga JJ; Schalij MJ; Bax JJ; Atsma DE
    Am Heart J; 2012 Nov; 164(5):771-8. PubMed ID: 23137509
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intramyocardial injection of autologous bone marrow mononuclear cells in patients with chronic myocardial infarction and severe left ventricular dysfunction.
    Beeres SL; Bax JJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; van der Wall EE; Schalij MJ; Atsma DE
    Am J Cardiol; 2007 Oct; 100(7):1094-8. PubMed ID: 17884369
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Direct minimally invasive intramyocardial injection of bone marrow-derived AC133+ stem cells in patients with refractory ischemia: preliminary results.
    Pompilio G; Steinhoff G; Liebold A; Pesce M; Alamanni F; Capogrossi MC; Biglioli P
    Thorac Cardiovasc Surg; 2008 Mar; 56(2):71-6. PubMed ID: 18278680
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Repeated Intramyocardial Bone Marrow Cell Injection in Previously Responding Patients With Refractory Angina Again Improves Myocardial Perfusion, Anginal Complaints, and Quality of Life.
    Mann I; Rodrigo SF; van Ramshorst J; Beeres SL; Dibbets-Schneider P; de Roos A; Wolterbeek R; Zwaginga JJ; Fibbe WE; Bax JJ; Schalij MJ; Atsma DE
    Circ Cardiovasc Interv; 2015 Aug; 8(8):. PubMed ID: 26259770
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Electrophysiological and arrhythmogenic effects of intramyocardial bone marrow cell injection in patients with chronic ischemic heart disease.
    Beeres SL; Zeppenfeld K; Bax JJ; Dibbets-Schneider P; Stokkel MP; Fibbe WE; van der Wall EE; Atsma DE; Schalij MJ
    Heart Rhythm; 2007 Mar; 4(3):257-65. PubMed ID: 17341383
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Effect of intramyocardial bone marrow cell injection on diastolic function in patients with chronic myocardial ischemia.
    Beeres SL; Lamb HJ; Roes SD; Holman ER; Kaandorp TA; Fibbe WE; de Roos A; van der Wall EE; Schalij MJ; Bax JJ; Atsma DE
    J Magn Reson Imaging; 2008 May; 27(5):992-7. PubMed ID: 18425845
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Predictors of response to intramyocardial bone marrow cell treatment in patients with refractory angina and chronic myocardial ischemia.
    Rodrigo SF; van Ramshorst J; Mann I; Leong DP; Cannegieter SC; Al Younis I; Dibbets-Schneider P; de Roos A; Fibbe WE; Zwaginga JJ; Bax JJ; Schalij MJ; Beeres SL; Atsma DE
    Int J Cardiol; 2014 Aug; 175(3):539-44. PubMed ID: 25023791
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Clinical outcome of patients with previous myocardial infarction and left ventricular dysfunction assessed with myocardial (99m)Tc-MIBI SPECT and (18)F-FDG PET.
    Zhang X; Liu XJ; Wu Q; Shi R; Gao R; Liu Y; Hu S; Tian Y; Guo S; Fang W
    J Nucl Med; 2001 Aug; 42(8):1166-73. PubMed ID: 11483675
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Intramyocardial bone marrow cell transplantation and the progression of coronary atherosclerosis in patients with chronic myocardial ischemia.
    Beeres SL; Bax JJ; Roes SD; Lamb HJ; Fibbe WE; De Roos A; Van Der Wall EE; Schalij MJ; Atsma DE
    Acute Card Care; 2007; 9(4):243-51. PubMed ID: 17926149
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Safety and feasibility of percutaneous retrograde coronary sinus delivery of autologous bone marrow mononuclear cell transplantation in patients with chronic refractory angina.
    Tuma J; Fernández-Viña R; Carrasco A; Castillo J; Cruz C; Carrillo A; Ercilla J; Yarleque C; Cunza J; Henry TD; Patel AN
    J Transl Med; 2011 Oct; 9():183. PubMed ID: 22029669
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effects of Transendocardial Delivery of Bone Marrow-Derived CD133
    Wojakowski W; Jadczyk T; Michalewska-Włudarczyk A; Parma Z; Markiewicz M; Rychlik W; Kostkiewicz M; Gruszczyńska K; Błach A; Dzier Zak-Mietła M; Wańha W; Ciosek J; Ochała B; Rzeszutko Ł; Cybulski W; Partyka Ł; Zasada W; Włudarczyk W; Dworowy S; Kuczmik W; Smolka G; Pawłowski T; Ochała A; Tendera M
    Circ Res; 2017 Feb; 120(4):670-680. PubMed ID: 27903568
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Linking cell function with perfusion: insights from the transcatheter delivery of bone marrow-derived CD133
    Bassetti B; Carbucicchio C; Catto V; Gambini E; Rurali E; Bestetti A; Gaipa G; Belotti D; Celeste F; Parma M; Righetti S; Biava L; Arosio M; Bonomi A; Agostoni P; Scacciatella P; Achilli F; Pompilio G
    Stem Cell Res Ther; 2018 Sep; 9(1):235. PubMed ID: 30217223
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Non-invasive detection of ischemic left ventricular dysfunction using rest gated SPECT: expectation of simultaneous evaluation of both myocardial perfusion and wall motion abnormality.
    Maeba H; Takehana K; Nakamura S; Yoshida S; Ueyama T; Hatada K; Iwasaka T
    Ann Nucl Med; 2008 May; 22(4):309-16. PubMed ID: 18535882
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Evaluation of left ventricular function using electrocardiographically gated myocardial SPECT with (123)I-labeled fatty acid analog.
    Nanasato M; Ando A; Isobe S; Nonokawa M; Hirayama H; Tsuboi N; Ito T; Hirai M; Yokota M; Saito H
    J Nucl Med; 2001 Dec; 42(12):1747-56. PubMed ID: 11752069
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evaluation of myocardial perfusion and function by gated single-photon emission computed tomography technetium-99m methoxyisobutylisonitrile in children and adolescents with severe congenital heart disease.
    Sobic-Saranovic DP; Pavlovic SV; Jovanovic IV; Stefanovic ID; Artiko VM; Djukic MM; Obradovic VB
    Nucl Med Commun; 2010 Jan; 31(1):12-21. PubMed ID: 19952920
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Dobutamine stress echocardiography and technetium-99m-tetrofosmin/fluorine 18-fluorodeoxyglucose single-photon emission computed tomography and influence of resting ejection fraction to assess myocardial viability in patients with severe left ventricular dysfunction and healed myocardial infarction.
    Rambaldi R; Poldermans D; Bax JJ; Boersma E; Valkema R; Elhendy A; Vletter WB; Fioretti PM; Roelandt JR; Krenning EP
    Am J Cardiol; 1999 Jul; 84(2):130-4. PubMed ID: 10426327
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 21.